FindTrial
Sign In

Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features

Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037644
Enrollment
Unknown
Registered
2020-08-29
Start date
2020-12-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

Gold Standard:IHC examination of PD-L1
the eighth edition of the TNM classification for lung cancer
Index test:PD-L1&#32
level
&#32
CEA&#32

Sponsors

Affiliated Hospital of Jiangnan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 79 Years

Inclusion criteria

Inclusion criteria: (a) patients who underwent biopsy or surgery of lung tumor; (b) IHC examination of PD-L1 performed; (c) pathologically proven histological type and grade available; and (d) standard chest CT performed before biopsy or surgery

Exclusion criteria

Exclusion criteria: (a) therapy (radiotherapy, chemotherapy or chemoradiotherapy) performed before CT and IHC; (b) histological grade unknown; and (c) CT images with artifacts

Design outcomes

Primary

MeasureTime frame
SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactYonggang Li
liyonggang224@163.com13776006850

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026